Answers are grounded in this paper and cite their sources.
Human immunodeficiency virus-1 (HIV-1) has a high degree of genetic and antigenic diversity that has impeded the development of an effective vaccine using traditional methods. We are attempting to develop an AIDS vaccine by employing strategies that include structural biology and computational modelling, in an effort to develop immunogens capable of eliciting neutralizing antibodies of the requisite breadth and potency against circulating strains of HIV-1.
No takes yet. Share an insight, caveat, or question.
Nabel et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: